|
Drug abuse
|
0.010 |
Biomarker
|
group |
BEFREE |
Specific significant associations included links between CAS and alcohol use (b = 0.40), childhood sexual abuse and unstable housing (b = - 0.75), alcohol use and childhood sexual abuse (b = 0.40), and substance use and intimate partner violence (b = 0.43).
|
31820288 |
2020 |
|
Exophthalmos
|
0.010 |
Biomarker
|
disease |
BEFREE |
There were significant differences in the case of exophthalmia (P=0.002), CAS (P=0.006), and Palpebral fissure (P=0.029) between the first visit and 6 months after treatment.
|
31345156 |
2020 |
|
Fatigue
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Fatigue gradually decreased after a peak at the 1st CTx cycle in Exp 2, whereas Exp 1 experienced increasing fatigue until the 3rd CTx cycle.
|
31129760 |
2020 |
|
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Taken together, our study revealed that CSE1L inhibition decreased MITF and suppressed GPNMB expression, thereby activating the PI3K/Akt/mTOR and MEK/ERK signaling pathway, ultimately inhibiting the tumor growth and metastasis in GC.
|
31347172 |
2020 |
|
Septicemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
CAS (%) is a new scoring system and works in accordance with the parameters in third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
|
31823148 |
2020 |
|
Sleep disturbances
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
A gradual decrease in sleep disturbance was observed in Exp 2 after the 2nd CTx cycle, whereas Exp 1 experienced a steady increase in the symptom.
|
31129760 |
2020 |
|
Violence
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Specific significant associations included links between CAS and alcohol use (b = 0.40), childhood sexual abuse and unstable housing (b = - 0.75), alcohol use and childhood sexual abuse (b = 0.40), and substance use and intimate partner violence (b = 0.43).
|
31820288 |
2020 |
|
Cancerophobia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This longitudinal study mapped distinct trajectories of Fear of cancer recurrence (FCR) over 12 months among patients with breast (BC) or colorectal (CRC) cancer, and examined if metacognition, indirectly via attentional bias, intrusive thoughts and avoidance (hallmarks of cognitive attentional syndrome; CAS) predicted FCR trajectory membership.
|
31663187 |
2020 |
|
Alcohol or Other Drugs use
|
0.010 |
Biomarker
|
disease |
BEFREE |
Specific significant associations included links between CAS and alcohol use (b = 0.40), childhood sexual abuse and unstable housing (b = - 0.75), alcohol use and childhood sexual abuse (b = 0.40), and substance use and intimate partner violence (b = 0.43).
|
31820288 |
2020 |
|
Sepsis
|
0.010 |
Biomarker
|
disease |
BEFREE |
CAS (%) is a new scoring system and works in accordance with the parameters in third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
|
31823148 |
2020 |
|
Intrusive thoughts
|
0.010 |
Biomarker
|
disease |
BEFREE |
This longitudinal study mapped distinct trajectories of Fear of cancer recurrence (FCR) over 12 months among patients with breast (BC) or colorectal (CRC) cancer, and examined if metacognition, indirectly via attentional bias, intrusive thoughts and avoidance (hallmarks of cognitive attentional syndrome; CAS) predicted FCR trajectory membership.
|
31663187 |
2020 |
|
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Taken together, our study revealed that CSE1L inhibition decreased MITF and suppressed GPNMB expression, thereby activating the PI3K/Akt/mTOR and MEK/ERK signaling pathway, ultimately inhibiting the tumor growth and metastasis in GC.
|
31347172 |
2020 |
|
Dyssomnias
|
0.010 |
Biomarker
|
disease |
BEFREE |
A gradual decrease in sleep disturbance was observed in Exp 2 after the 2nd CTx cycle, whereas Exp 1 experienced a steady increase in the symptom.
|
31129760 |
2020 |
|
Sleep Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
A gradual decrease in sleep disturbance was observed in Exp 2 after the 2nd CTx cycle, whereas Exp 1 experienced a steady increase in the symptom.
|
31129760 |
2020 |
|
Congenital Abnormality
|
0.010 |
Biomarker
|
group |
BEFREE |
Cyanide produced with ethylene by ACS and its incomplete detoxification by β-CAS in mango inflorescence leads to malformation.
|
31797981 |
2019 |
|
Atrial Fibrillation
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the ACE2 variant rs2074192 was associated with EH and EH with CAS ≥50%, while 3 ACE2 variants (rs4240157, rs4646155, and rs4830542) were associated with EH- and hypertension-related AF and left atrial remodeling in south Xinjiang, China.
|
30542083 |
2019 |
|
Cerebral Embolism
|
0.010 |
Biomarker
|
disease |
BEFREE |
The risk of cerebral embolism after CAS in patients with carotid IPH is still controversial.
|
31025147 |
2019 |
|
Mental Depression
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The 5-item Mandarin CAS-R was associated with higher levels of self-care maintenance (β = 0.395, P < .001), management (β = 0.219, P < .01), and confidence (β = 0.524, P < .001); perceived social support (β = 0.246, P < .001); and depression (β = -0.125, P < .05).
|
28628499 |
2019 |
|
Depressive disorder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The 5-item Mandarin CAS-R was associated with higher levels of self-care maintenance (β = 0.395, P < .001), management (β = 0.219, P < .01), and confidence (β = 0.524, P < .001); perceived social support (β = 0.246, P < .001); and depression (β = -0.125, P < .05).
|
28628499 |
2019 |
|
Dysarthria
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Abbreviations</b>: CAS: Childhood Apraxia of Speech; CD: Childhood Dysarthria; DS: Down syndrome; II: Intelligibility Index; No MSD: No Motor Speech Disorder; OII: Ordinal Intelligibility Index; PSD: Persistent Speech Delay; SDCS: Speech Disorders Classification System; SMD: Speech Motor Delay.
|
31221010 |
2019 |
|
Heart failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to translate, culturally adapt, and validate the Mandarin version of the Control Attitudes Scale-Revised (Mandarin CAS-R) in Taiwanese patients with HF.
|
28628499 |
2019 |
|
Congestive heart failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to translate, culturally adapt, and validate the Mandarin version of the Control Attitudes Scale-Revised (Mandarin CAS-R) in Taiwanese patients with HF.
|
28628499 |
2019 |
|
Laryngeal neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The role of CSE1L expression in cervical lymph node metastasis of larynx tumors.
|
31383592 |
2019 |
|
Obesity
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
None of the CAS parameters were associated with any measures of obesity.
|
30770289 |
2019 |
|
Osteitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Effect of antibiotic infused calcium sulfate/hydroxyapatite (CAS/HA) insets on implant-associated osteitis in a femur fracture model in mice.
|
30870491 |
2019 |